KDST Intrinsic Valuation and Fundamental Analysis - Kadimastem Ltd

Watchlist Manager

Watchlist

Price: 2 794 ILS -1.13% Market Closed

Market Cap: ₪117.9m

K	Kadimastem Ltd TASE:KDST	IL
	Kruk SA F:83I	PL
E	Eksons Corporation Bhd KLSE:EKSONS	MY
S	Seoyon TopMetal Co Ltd KOSDAQ:019770	KR
I	Immuron Ltd F:ANW	AU
F	Firm Capital Mortgage Investment Corp F:74X	CA
A	African Pioneer PLC F:9TI	IM
S	Sony Group Corp XMUN:SON1	JP
	Medistim ASA OSE:MEDI	NO
A	AMETEK Inc XMUN:AK1	US

Intrinsic Value

Is KDST undervalued or overvalued?

See the intrinsic value estimate for Kadimastem Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

KDST Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with KDST’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price ₪2 794

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Kadimastem Does

Biotechnology Health Care

Kadimastem is a regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The Company’s technology enables the differentiation of stem cells into insulin secreting beta cells, as well as a range of neural cells (including Oligodendrocytes, Astrocytes). The firm produces islet-like clusters that show glucose-stimulated insulin secretion.

Headquarters: Israel IL
IPO date: Jun 9, 2013